Calcium Channels in the Heart: Disease States and Drugs

Kajol Shah1, Sarah Seeley2, Castin Schulz2

  • 1Internal Medicine at Rutgers, New Jersey Medical School, Newark, NJ 07103, USA.

Cells
|March 25, 2022
PubMed

Insights

Calcium ions are vital cell signals regulating heart function via L-type and T-type calcium channels. Understanding these channels and blockers aids in treating cardiac disorders like arrhythmias and hypertension.

Area of Science:

  • Cardiology
  • Cellular Physiology
  • Pharmacology

Background:

  • Calcium ions (Ca2+) are critical intracellular signaling molecules.
  • They regulate diverse cellular processes, including muscle contraction, neurotransmission, and cell growth.
  • Calcium ion influx into cells is controlled by specific ion channels and transporters.

Purpose of the Study:

  • To review the types, functions, and roles of cardiac calcium channels.
  • To discuss diseases and disorders arising from calcium channel mutations or dysfunction.
  • To summarize calcium channel blockers and their therapeutic applications in cardiovascular diseases.

Main Methods:

  • Literature review of cardiac calcium channel types (L-type, T-type).
  • Analysis of calcium channel roles in cardiac conduction and pacemaker activity.
  • Examination of disease mechanisms linked to calcium channel defects.
  • Overview of pharmacological strategies targeting calcium channels.

Main Results:

  • Two prominent calcium channel types in the heart: L-type (ubiquitous) and T-type (specific cells).
  • Both channel types are crucial for atrioventricular conduction and pacemaker activity.
  • Calcium channel dysfunctions are implicated in various cardiac conditions.
  • Calcium channel blockers are established treatments for hypertension, angina, and arrhythmias.

Conclusions:

  • Cardiac calcium channels, particularly L-type and T-type, are essential for normal heart function.
  • Defects in these channels lead to significant cardiovascular diseases.
  • Targeting calcium channels with specific blockers is a cornerstone of cardiovascular pharmacotherapy.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
877
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.9K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.1K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
741
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.7K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.3K